Moreover, although cancer cell lines are representative of the different colorectal cancer molecular subtypes, which validates their utility as tools to investigate tumor biology and drug response73,74, future studies will be necessary to evaluate the impact of ERK5 inhibition on patient-derived in vitro and in vivo models. The gene discussed is MAPK7; the disease is neoplasm.